1-4 of 4
H. Avet-Loiseau
Close
Sort by
Journal Articles

Maintenance Treatment with Lenalidomide After Transplantation for MYELOMA: Final Analysis of the IFM 2005-02.

Michel Attal, MD, Valerie cances Lauwers, Gerald Marit, Service, d'hématologie, clinique, et, de, thérapie, cellulaire, Denis Caillot, Thierry Facon, MD, Cyrille Hulin, Philippe Moreau, MD, Claire Mathiot, Murielle Roussel, Catherine Payen, H. Avet-Loiseau, jean Luc Harousseau
Journal: Blood
Blood (2010) 116 (21): 310.
https://doi.org/10.1182/blood.V116.21.310.310
Published: 2010
Journal Articles

A High Density Polymorphism Analysis of Factors Correlated with Neurotoxicity to Bortezomib in Patients with Multiple Myeloma.

Stephane Minvielle, Ph.D, Céline Keime, Florence Magrangeas, Julie Vendrell, Wilfried Gouraud, Sergio Rodrigues de Morais, Stephanie Montesinos, Charles Dumontet, H. Avet-Loiseau
Journal: Blood
Blood (2009) 114 (22): 4816.
https://doi.org/10.1182/blood.V114.22.4816.4816
Published: 2009
Journal Articles

Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

Heinz Ludwig, B. Durie, V. Bolejack, A. Hoering, M. Dimopoulos, R. Kyle, R. Fonseca, M. Beksac, J. San Miguel, J. Crowley, J. Blade, M. Boccadoro, H. Avet Loiseau, G. Morgan, K. Shimizu, C. Shustik, P. Sonneveld, P. Tosi, I. Turesson, J. Westin
Journal: Blood
Blood (2005) 106 (11): 3414.
https://doi.org/10.1182/blood.V106.11.3414.3414
Published: 2005
Journal Articles

Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia

B Mehrotra, TI George, K Kavanau, H Avet-Loiseau, D 2nd Moore, CL Willman, ML Slovak, S Atwater, DR Head, MG Pallavicini
Journal: Blood
Blood (1995) 86 (3): 1139–1147.
https://doi.org/10.1182/blood.V86.3.1139.1139
Published: 1995